Astellas Pharma gets global rights to an Evopoint Biosciences antibody drug conjugate that targets Claudin 18.2. Last year, Astellas’s antibody drug Vyloy became the first FDA-approved therapy for this target. The post Astellas Stays Competitive in Hot Gut Cancer Target, Paying $130M to License Evopoint Drug appeared first on MedCity News.
Health tech companies made several major funding announcements in May. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in May appeared first on MedCity News.
May has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, the American Medical Association and TigerConnect named new CEOs, and Google and UnitedHealth Group have seen key executives leave their roles. There were also layoffs at organizations including Devoted Health and New York-Presbyterian. The post Healthcare Moves: A…
In this episode, we’re joined by Margaret Malone, principal of Flare Capital Partners. She discusses the investment trends she’s following in the women’s health space and advice she has for startups. The post MedCity FemFwd: Investment Trends In Women’s Health appeared first on MedCity News.
By treating model governance as a proactive, integral part of operations rather than a box to check after the fact, life sciences organizations can uphold compliance, better allocate their resources, and gain a competitive edge. The post Innovate or Stagnate: Overcoming Model Governance Challenges in Life Sciences appeared first on MedCity News.
Workplace violence prevention is an ongoing and organic process. Federal and state regulations change frequently, so employers may consider regularly reviewing and updating their prevention plans and training programs on a scheduled timeline. The post Workplace Violence Prevention in 2025 appeared first on MedCity News.
Pfizer drug Braftovi achieved statistically significant and clinically meaningful improvement in overall survival for colorectal cancer patients in a Phase 3 clinical trial. The results will be presented Friday during the annual meeting of the American Society of Clinical Oncology. The post Precision Pfizer Drug Leads to ‘Unprecedented’ Survival in Colorectal Cancer, Data at ASCO…
Priority Health has partnered with Virta Health to offer a suite of diabetes and weight management solutions to its employer clients. The post Priority Health Teams Up with Virta Health for Diabetes, Weight Loss Support appeared first on MedCity News.
Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market. The post Why Is Medtronic Spinning Off Its Diabetes Business? appeared first on MedCity…
Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing. But the Department of Health and Human Services has canceled a $590 million contract to support Moderna’s pivotal trial. The post Bird Flu Threat Still…